Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 1
Submit an article Journal homepage
2,495
Views
35
CrossRef citations to date
0
Altmetric
Original Research

BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)

Audrey BenyamineInserm, U1068, Centre de Recherche en Cancérologie de Marseille (CRCM), Immunity & Cancer, Institut Paoli-Calmettes; Aix-Marseille Université UM 105; CNRS UMR 7258, Marseille, FranceCorrespondence[email protected] [email protected]
,
Céline LoncleInserm, U1068, Centre de Recherche en Cancérologie de Marseille (CRCM), Cellular Stress, Institut Paoli-Calmettes; Aix-Marseille Université UM 105; CNRS UMR 7258, Parc Scientifique et Technologique de Luminy, Marseille, France;Dynabio, Luminy Biotech Entreprises, Marseille, France
,
Etienne FoucherInserm, U1068, Centre de Recherche en Cancérologie de Marseille (CRCM), Immunity & Cancer, Institut Paoli-Calmettes; Aix-Marseille Université UM 105; CNRS UMR 7258, Marseille, France
,
Juan-Luis BlazquezInserm, U1068, Centre de Recherche en Cancérologie de Marseille (CRCM), Immunity & Cancer, Institut Paoli-Calmettes; Aix-Marseille Université UM 105; CNRS UMR 7258, Marseille, FranceORCID Iconhttp://orcid.org/0000-0003-1822-2237
ORCID Icon,
Céline CastanierInserm, U1068, Centre de Recherche en Cancérologie de Marseille (CRCM), Immunity & Cancer, Institut Paoli-Calmettes; Aix-Marseille Université UM 105; CNRS UMR 7258, Marseille, France
,
Anne-Sophie ChrétienInserm, U1068, Centre de Recherche en Cancérologie de Marseille (CRCM), Immunity & Cancer, Institut Paoli-Calmettes; Aix-Marseille Université UM 105; CNRS UMR 7258, Marseille, France
,
Mauro ModestiInserm, U1068, Centre de Recherche en Cancérologie de Marseille (CRCM), Homologous Recombination, NHEJ and Maintenance of Genomic Integrity; Aix-Marseille Université UM 105; CNRS UMR 7258, Marseille, France
,
Véronique SecqDepartment of Pathology, Hôpital Nord / Aix-Marseille Université, Marseille, France
,
Salem ChouaibINSERM UMR1186, Laboratory «Integrative Tumor Immunology and Genetic Oncology»; INSERM, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay Villejuif, Villejuif, France
,
Meritxell GironellaGastrointestinal & Pancreatic Oncology Group, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD)/Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain
,
Elena Vila-NavarroGastrointestinal & Pancreatic Oncology Group, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD)/Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain
,
Giuseppe MontaltoBiomedical Department of Internal Medicine and Specialties (DiBiMIS), University of Palermo, Institute of Biomedicine and Molecular Immunology “Alberto Monroy”, National Research Council (CNR), Palermo, ItalyORCID Iconhttp://orcid.org/0000-0002-8731-8577
ORCID Icon,
Jean-Charles DagornDynabio, Luminy Biotech Entreprises, Marseille, France
,
Nelson DusettiInserm, U1068, Centre de Recherche en Cancérologie de Marseille (CRCM), Cellular Stress, Institut Paoli-Calmettes; Aix-Marseille Université UM 105; CNRS UMR 7258, Parc Scientifique et Technologique de Luminy, Marseille, France
,
Juan IovannaInserm, U1068, Centre de Recherche en Cancérologie de Marseille (CRCM), Cellular Stress, Institut Paoli-Calmettes; Aix-Marseille Université UM 105; CNRS UMR 7258, Parc Scientifique et Technologique de Luminy, Marseille, France
&
Daniel OliveInserm, U1068, Centre de Recherche en Cancérologie de Marseille (CRCM), Immunity & Cancer, Institut Paoli-Calmettes; Aix-Marseille Université UM 105; CNRS UMR 7258, Marseille, France;Immunomonitoring Platform Aix-Marseille Université, Marseille, France;Immunomonitoring Platform Institut Paoli-Calmettes, 232 Bd Sainte Marguerite, Marseille, FranceCorrespondence[email protected] [email protected]
 show all
Article: e1372080 | Received 13 Jul 2017, Accepted 23 Aug 2017, Published online: 21 Sep 2017

Citations (35)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Huimin Lu, Tongguo Shi, Mingyuan Wang, Xiaomi Li, Yanzheng Gu, Xueguang Zhang, Guangbo Zhang & Weichang Chen. (2020) B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells. OncoImmunology 9:1.
Read now
Benjamin Bian, Daniele Fanale, Nelson Dusetti, Julie Roque, Sonia Pastor, Anne-Sophie Chretien, Lorena Incorvaia, Antonio Russo, Daniel Olive & Juan Iovanna. (2019) Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma. OncoImmunology 8:4.
Read now

Articles from other publishers (33)

Patricia Hernández-López, Eline van Diest, Peter Brazda, Sabine Heijhuurs, Angelo Meringa, Lauren Hoorens van Heyningen, Caterina Riillo, Caroline Schwenzel, Marina Zintchenko, Inez Johanna, Mara J. T. Nicolasen, Astrid Cleven, Thomas A. Kluiver, Rosemary Millen, Jiali Zheng, Froso Karaiskaki, Trudy Straetemans, Hans Clevers, Remco de Bree, Hendrik G. Stunnenberg, Weng Chuan Peng, Jeanine Roodhart, Susana Minguet, Zsolt Sebestyén, Dennis X. Beringer & Jürgen Kuball. (2023) Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells. Nature Immunology.
Crossref
Ivan Pasic, Annie H. Ren, Ram Vasudevan Nampoothiri, Ioannis Prassas, Jeffrey H. Lipton, Jonas Mattsson, Eleftherios P. Diamandis & Fotios V. Michelis. (2023) Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation. Clinical Chemistry and Laboratory Medicine (CCLM) 61:6, pages 1005-1014.
Crossref
Zhifei Gao, Yifeng Bai, Anqi Lin, Aimin Jiang, Chaozheng Zhou, Quan Cheng, Zaoqu Liu, Xin Chen, Jian Zhang & Peng Luo. (2023) Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment. Molecular Cancer 22:1.
Crossref
Perla Abou Atmeh, Laetitia Gay, Anthony Levasseur, Bernard La Scola, Daniel Olive, Soraya Mezouar, Jean-Pierre Gorvel & Jean-Louis Mege. (2022) Macrophages and γδ T cells interplay during SARS-CoV-2 variants infection. Frontiers in Immunology 13.
Crossref
Abdou-samad Kone, Saadia Ait Ssi, Souha Sahraoui & Abdallah Badou. (2022) BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment. International Journal of Molecular Sciences 23:21, pages 13424.
Crossref
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, Sofia Cutaia, Mariano Catello Di Donna, Clarissa Filorizzo, Maria Chiara Lisanti, Ugo Randazzo, Luigi Magrin, Raffaella Romano, Tancredi Didier Bazan Russo, Daniel Olive, Salvatore Vieni, Gianni Pantuso, Vito Chiantera, Antonio Russo, Viviana Bazan & Juan Lucio Iovanna. (2022) Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?. Frontiers in Oncology 12.
Crossref
Laetitia Gay, Soraya Mezouar, Carla Cano, Paul Frohna, Loui Madakamutil, Jean-Louis Mège & Daniel Olive. (2022) Role of Vγ9vδ2 T lymphocytes in infectious diseases. Frontiers in Immunology 13.
Crossref
Yuansheng Lin, Hao Zhou & Shengjun Li. (2022) BTN3A2 Expression Is Connected With Favorable Prognosis and High Infiltrating Immune in Lung Adenocarcinoma. Frontiers in Genetics 13.
Crossref
Fatemeh Nezhad Shamohammadi, Mahboubeh Yazdanifar, Mona Oraei, Mohammad H Kazemi, Azam Roohi, Seyedeh Mahya Shariat razavi, Farhad Rezaei, Farzad Parvizpour, Yalda Karamlou & Haideh Namdari. (2022) Controversial role of γδ T cells in pancreatic cancer. International Immunopharmacology 108, pages 108895.
Crossref
Laetitia Gay, Soraya Mezouar, Carla Cano, Etienne Foucher, Mélanie Gabriac, Marie Fullana, Loui Madakamutil, Jean-Louis Mège & Daniel Olive. (2022) BTN3A Targeting Vγ9Vδ2 T Cells Antimicrobial Activity Against Coxiella burnetii-Infected Cells. Frontiers in Immunology 13.
Crossref
José Saura-Esteller, Milon de Jong, Lisa A. King, Erik Ensing, Benjamin Winograd, Tanja D. de Gruijl, Paul W. H. I. Parren & Hans J. van der Vliet. (2022) Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future. Frontiers in Immunology 13.
Crossref
Elena Lo Presti, Laura D’Orsi & Andrea De Gaetano. (2022) A Mathematical Model of In Vitro Cellular Uptake of Zoledronic Acid and Isopentenyl Pyrophosphate Accumulation. Pharmaceutics 14:6, pages 1262.
Crossref
Yue Wang, Yi Xu, Hui Chen, Jianmin Zhang & Wei He. (2022) Novel insights based on the plasticity of γδ T cells in the tumor microenvironment. Exploration of Immunology, pages 98-132.
Crossref
Shuangfeng Yang, Yuan-Liang Wang, Yanping Lyu, Yu Jiang, Jianjun Xiang, Shumi Ji, Shuling Kang, Xuejie Lyu, Chenzhou He, Peixin Li, Baoying Liu & Chuancheng Wu. (2021) mGWAS identification of six novel single nucleotide polymorphism loci with strong correlation to gastric cancer. Cancer & Metabolism 9:1.
Crossref
Aude De Gassart, Kieu-Suong Le, Patrick BruneSophie AgauguéJennifer SimsArmelle GoubardRémy CastellanoNoémie JoallandEmmanuel Scotet, Yves Collette, Emmanuel Valentin, Clement GhigoChristine Pasero, Magali Colazet, Jaime Guillén, Carla E. CanoAurélien Marabelle, Johann De Bonno, René HoetAlemseged TrunehDaniel OlivePaul Frohna. (2021) Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response. Science Translational Medicine 13:616.
Crossref
Tianyu Zheng, Jinrong Huang, Xi Xiang, Siyuan Li, Jiaying Yu, Kunli Qu, Zhe Xu, Peng Han, Zhanying Dong, Yang Liu, Fengping Xu, Huanming Yang, Marja Jäättelä, Yonglun Luo & Bin Liu. (2021) Systematical analysis reveals a strong cancer relevance of CREB1-regulated genes. Cancer Cell International 21:1.
Crossref
Carla E. Cano, Christine Pasero, Aude De Gassart, Clement Kerneur, Mélanie Gabriac, Marie Fullana, Emilie Granarolo, René Hoet, Emmanuel Scotet, Chirine Rafia, Thomas Herrmann, Caroline Imbert, Laurent Gorvel, Norbert Vey, Antoine Briantais, Anne Charlotte le Floch & Daniel Olive. (2021) BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells. Cell Reports 36:2, pages 109359.
Crossref
Daniele Fanale, Lorena Incorvaia, Giuseppe Badalamenti, Ida De Luca, Laura Algeri, Annalisa Bonasera, Lidia Rita Corsini, Chiara Brando, Antonio Russo, Juan Lucio Iovanna & Viviana Bazan. (2021) Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?. Cancers 13:9, pages 2118.
Crossref
Emilien Billon, Brice Chanez, Philippe Rochigneux, Laurence Albiges, Cécile Vicier, Géraldine Pignot, Jochen Walz, Anne-Sophie Chretien, Gwenaelle Gravis & Daniel Olive. (2021) Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma. Frontiers in Immunology 12.
Crossref
Anh Thu Dang, Juliane Strietz, Alessandro Zenobi, Hanif J. Khameneh, Simon M. Brandl, Laura Lozza, Gregor Conradt, Stefan H.E. Kaufmann, Walter Reith, Ivo Kwee, Susana Minguet, Sonia T. Chelbi & Greta Guarda. (2021) NLRC5 promotes transcription of BTN3A1-3 genes and Vγ9Vδ2 T cell-mediated killing. iScience 24:1, pages 101900.
Crossref
Olamide T. Olaoba, Funmilayo C. Ligali, Zaccheaus O. Alabi, Amos O. Akinyemi & Kehinde S. Ayinde. (2021) Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:1, pages 188483.
Crossref
Pauline Girard, Eleonora Sosa Cuevas, Benedicte Ponsard, Stephane Mouret, Hugo Gil, Edwige Col, Florence De Fraipont, Nathalie Sturm, Julie Charles, Olivier Manches, Laurence Chaperot & Caroline Aspord. (2021) Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes. Clinical & Translational Immunology 10:11.
Crossref
Huanzi Lu, Wenxiao Dai, Junyi Guo, Dikan Wang, Shuqiong Wen, Lisa Yang, Dongjia Lin, Wenqiang Xie, Liling Wen, Juan Fang & Zhi Wang. (2020) High Abundance of Intratumoral γδ T Cells Favors a Better Prognosis in Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis. Frontiers in Immunology 11.
Crossref
Jing Ni, Bin Deng, Meng Zhu, Yuzhuo Wang, Caiwang Yan, Tianpei Wang, Yaqian Liu, Gang Li, Yanbing Ding & Guangfu Jin. (2020) Integration of GWAS and eQTL Analysis to Identify Risk Loci and Susceptibility Genes for Gastric Cancer. Frontiers in Genetics 11.
Crossref
S K Sureshbabu, D Chaukar & S V Chiplunkar. (2020) Hypoxia regulates the differentiation and anti-tumor effector functions of γδT cells in oral cancer. Clinical and Experimental Immunology 201:1, pages 40-57.
Crossref
Thomas Herrmann, Alina Suzann Fichtner & Mohindar Murugesh Karunakaran. (2020) An Update on the Molecular Basis of Phosphoantigen Recognition by Vγ9Vδ2 T Cells. Cells 9:6, pages 1433.
Crossref
Klaus-Peter Künkele, Daniela Wesch, Hans-Heinrich Oberg, Martin Aichinger, Verena Supper & Christoph Baumann. (2020) Vγ9Vδ2 T Cells: Can We Re-Purpose a Potent Anti-Infection Mechanism for Cancer Therapy?. Cells 9:4, pages 829.
Crossref
Peian Cai, Zhenhui Lu, Jianjun Wu, Xiong Qin, Zetao Wang, Zhi Zhang, Li Zheng & Jinmin Zhao. (2019) BTN3A2 serves as a prognostic marker and favors immune infiltration in triple‐negative breast cancer. Journal of Cellular Biochemistry 121:3, pages 2643-2654.
Crossref
Caroline Imbert & Daniel Olive. 2020. Tumor Microenvironment. Tumor Microenvironment 91 104 .
Qi Chen, Jianxin Wang, Wei Chen, Qi Zhang, Tao Wei, Yue Zhou, Xingyuan Xu, Xueli Bai & Tingbo Liang. (2019) B7‐H5/ CD 28H is a co‐stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma . Cancer Science 110:2, pages 530-539.
Crossref
Juan-Luis Blazquez, Audrey Benyamine, Christine Pasero & Daniel Olive. (2018) New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity. Frontiers in Immunology 9.
Crossref
Zhan Wang, Zenan Wang, Shu Li, Binghao Li, Lingling Sun, Hengyuan Li, Peng Lin, Shengdong Wang, Wangsiyuan Teng, Xingzhi Zhou & Zhaoming Ye. (2018) Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis. Frontiers in Immunology 9.
Crossref
Etienne D. Foucher, Clément Ghigo, Salem Chouaib, Jérôme Galon, Juan Iovanna & Daniel Olive. (2018) Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment. Frontiers in Immunology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.